Your browser doesn't support javascript.
loading
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
Hirsch, Fred R; McElhinny, Abigail; Stanforth, Dave; Ranger-Moore, James; Jansson, Malinka; Kulangara, Karina; Richardson, William; Towne, Penny; Hanks, Debra; Vennapusa, Bharathi; Mistry, Amita; Kalamegham, Rasika; Averbuch, Steve; Novotny, James; Rubin, Eric; Emancipator, Kenneth; McCaffery, Ian; Williams, J Andrew; Walker, Jill; Longshore, John; Tsao, Ming Sound; Kerr, Keith M.
Afiliación
  • Hirsch FR; Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado; International Association for the Study of Lung Cancer, Aurora, Colorado. Electronic address: Fred.Hirsch@ucdenver.edu.
  • McElhinny A; Personal Genome Diagnostics, Baltimore, Maryland.
  • Stanforth D; Dako North America, Agilent Technologies, Carpinteria, California.
  • Ranger-Moore J; Ventana Medical Systems, Inc., Roche Tissue Diagnostics, Tucson, Arizona.
  • Jansson M; Dako North America, Agilent Technologies, Carpinteria, California.
  • Kulangara K; Dako North America, Agilent Technologies, Carpinteria, California.
  • Richardson W; Ventana Medical Systems, Inc., Roche Tissue Diagnostics, Tucson, Arizona.
  • Towne P; Ventana Medical Systems, Inc., Roche Tissue Diagnostics, Tucson, Arizona.
  • Hanks D; Dako North America, Agilent Technologies, Carpinteria, California.
  • Vennapusa B; Ventana Medical Systems, Inc., Roche Tissue Diagnostics, Tucson, Arizona.
  • Mistry A; Ventana Medical Systems, Inc., Roche Tissue Diagnostics, Tucson, Arizona.
  • Kalamegham R; American Association for Cancer Research, Washington, DC; Genentech, Washington, DC.
  • Averbuch S; Development, Oncology and Pharmacodiagnostics, Bristol-Myers Squibb Company, Princeton, New Jersey.
  • Novotny J; Development, Oncology and Pharmacodiagnostics, Bristol-Myers Squibb Company, Princeton, New Jersey.
  • Rubin E; Merck & Co., Inc., Kenilworth, New Jersey.
  • Emancipator K; Merck & Co., Inc., Kenilworth, New Jersey.
  • McCaffery I; Genentech, Oncology Biomarkers Development, South San Francisco, California; Corvus Pharmaceuticals, Burlingame, California.
  • Williams JA; Genentech, Oncology Biomarkers Development, South San Francisco, California.
  • Walker J; AstraZeneca, Cambridge, United Kingdom.
  • Longshore J; Carolinas Pathology Group, Carolinas HealthCare System, Charlotte, North Carolina.
  • Tsao MS; Department of Pathology, University Health Network, Princess Margaret Cancer Centre and University of Toronto, Ontario, Canada.
  • Kerr KM; Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, Scotland.
J Thorac Oncol ; 12(2): 208-222, 2017 02.
Article en En | MEDLINE | ID: mdl-27913228
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bioensayo / Inmunohistoquímica / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bioensayo / Inmunohistoquímica / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2017 Tipo del documento: Article